Replies to post #150292 on Biotech Values

[masterlongevity]

OK. Based on the recent bapineuzumab and solanezumab results

what are the odds that lilly will be able to file an accelerated approval?
<5% chance, 6-20% chance, 21-50%, > than 50

what are the odds that Lilly conduct an additional ph 3 trial with solanezumab?
<20% chance, 21-60% chance, 61-90% chance, >90% chance

What are the odds of ultimate ph 3 success with solanezumab
<5%, 6- 25%, 26-50%, 51-75%, >75%